Labcorp Holdings Inc. Declares Quarterly Dividend of $0.72 (NYSE:LH)

Labcorp Holdings Inc. (NYSE:LH) declared a quarterly dividend on Thursday, July 9th. Investors of record on Friday, August 28th will be given a dividend of 0.72 per share by the medical research company on Friday, September 11th. This represents a c) dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Friday, August 28th.

Labcorp has a dividend payout ratio of 16.4% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Labcorp to earn $19.33 per share next year, which means the company should continue to be able to cover its $2.88 annual dividend with an expected future payout ratio of 14.9%.

Labcorp Price Performance

LH stock opened at $277.51 on Friday. The stock has a market cap of $22.76 billion, a PE ratio of 24.58, a P/E/G ratio of 1.94 and a beta of 0.89. Labcorp has a 12 month low of $241.81 and a 12 month high of $293.72. The company has a 50-day moving average price of $263.69 and a 200 day moving average price of $267.01. The company has a current ratio of 1.73, a quick ratio of 1.54 and a debt-to-equity ratio of 0.68.

Labcorp (NYSE:LH) last announced its quarterly earnings data on Thursday, April 30th. The medical research company reported $4.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.09 by $0.16. The business had revenue of $3.54 billion during the quarter, compared to the consensus estimate of $3.51 billion. Labcorp had a net margin of 6.66% and a return on equity of 16.29%. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the firm earned $3.84 earnings per share. Labcorp has set its FY 2026 guidance at 17.700-18.350 EPS. Equities research analysts anticipate that Labcorp will post 18 earnings per share for the current year.

Labcorp Company Profile

Laboratory Corporation of America Holdings, commonly known as Labcorp (NYSE: LH), is a global life sciences company that provides comprehensive clinical laboratory and drug development services. The company operates a broad network of laboratories, patient service centers and specialty testing sites to deliver diagnostic information and testing solutions that support patient care, clinical decision-making and population health initiatives.

Labcorp’s core businesses encompass clinical laboratory testing and pharmaceutical development services.